Mometason Glenmark (Mometasone Furoate)

Mometasone furoate penetrates skin cells and binds to glucocorticoid receptors inside the nucleus. This complex alters gene transcription, suppressing the production of inflammatory mediators like cytokines, prostaglandins and leukotrienes, and inhibits immune‑cell activation, thereby providing strong anti‑inflammatory and immunosuppressive effects locally.

The dosage of Mometason Glenmark is individualized by the prescribing clinician based on the severity of the skin condition, the area to be treated and patient age. The prescriber determines the amount, frequency and duration of application, and patients should follow the written instructions precisely.

Safety data for topical mometasone furoate in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by the treating physician after evaluating the clinical situation.

To request Mometason Glenmark, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone furoate is a high‑potency class II topical corticosteroid, offering stronger anti‑inflammatory action than low‑potency agents such as hydrocortisone, but with a lower risk of systemic effects compared with very high‑potency steroids like clobetasol. Its efficacy and safety profile make it suitable for moderate to severe dermatoses when used as directed.

Store Mometason Glenmark at room temperature, preferably below 25 °C, in its original packaging. Keep the container tightly closed, protect it from excess moisture and direct sunlight, and ensure it is out of reach of children.

Apply a thin layer of the product to clean, dry skin on the affected area, usually once or twice daily as prescribed. Gently rub it in until fully absorbed, avoid contact with eyes, mucous membranes and broken skin unless instructed, and wash hands after application.

Serious adverse events, though rare, include skin atrophy, hypopigmentation, secondary infections, systemic adrenal suppression with extensive use, and severe allergic reactions such as contact dermatitis. Patients should report any unusual skin changes, signs of infection or systemic symptoms to their healthcare provider promptly.

Mometason Glenmark should be avoided in individuals with known hypersensitivity to mometasone furoate or any formulation excipients, in patients with untreated fungal, bacterial or viral skin infections, and in those where a less potent corticosteroid would be sufficient. Use in children under two years of age requires special medical supervision.